Acorn Asks For More Help From Investors After FDA Panel Denies CorCap PMA

Acorn Cardiovascular says it will ask its current investors to fund a confirmatory trial of its CorCap Cardiac Support Device after an FDA advisory panel decided more research is needed before it could support premarket approval